Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level
The biological processes that are disrupted in the Alzheimer's disease (AD) brain remain
incompletely understood. In this study, we analyzed the proteomes of more than 1,000 brain …
incompletely understood. In this study, we analyzed the proteomes of more than 1,000 brain …
Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies
Improved understanding of genetic regulation of the proteome can facilitate identification of
the causal mechanisms for complex traits. We analyzed data on 4,657 plasma proteins from …
the causal mechanisms for complex traits. We analyzed data on 4,657 plasma proteins from …
Mendelian randomization applied to neurology: promises and challenges
The Mendelian randomization (MR) paradigm allows for causal inferences to be drawn
using genetic data. In recent years, the expansion of well-powered publicly available genetic …
using genetic data. In recent years, the expansion of well-powered publicly available genetic …
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach 1
J Timsina, D Gomez-Fonseca, L Wang… - Journal of …, 2022 - content.iospress.com
Background: The SOMAscan assay has an advantage over immunoassay-based methods
because it measures a large number of proteins in a cost-effective manner. However, the …
because it measures a large number of proteins in a cost-effective manner. However, the …
Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease
R Tarawneh, RS Kasper, J Sanford… - Annals of clinical …, 2022 - Wiley Online Library
Objective Endothelial dysfunction is an early and prevalent pathology in Alzheimer disease
(AD). We here investigate the value of vascular endothelial‐cadherin (VEC) as a …
(AD). We here investigate the value of vascular endothelial‐cadherin (VEC) as a …
Integrating human brain proteomic data with genome-wide association study findings identifies novel brain proteins in substance use traits
Despite the identification of a growing number of genetic risk loci for substance use traits
(SUTs), the impact of these loci on protein abundance and the potential utility of relevant …
(SUTs), the impact of these loci on protein abundance and the potential utility of relevant …
Large Bi-Ethnic Study of Plasma Proteome Leads to Comprehensive Mapping of cis-pQTL and Models for Proteome-wide Association Studies
Improved understanding of the genetic architecture of the proteome through studies of larger
sample size, ethnic diversity, and advanced methods can facilitate the identification of …
sample size, ethnic diversity, and advanced methods can facilitate the identification of …
A trans‐omic Mendelian randomization study of parental lifespan uncovers novel aging biology and therapeutic candidates for chronic diseases
N Perrot, W Pelletier, J Bourgault, C Couture, Z Li… - Aging …, 2021 - Wiley Online Library
The study of parental lifespan has emerged as an innovative tool to advance aging biology
and our understanding of the genetic architecture of human longevity and aging‐associated …
and our understanding of the genetic architecture of human longevity and aging‐associated …
Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease
Alpha-synuclein is the main protein component of Lewy bodies, the pathological hallmark of
Parkinson's disease. However, genetic modifiers of cerebrospinal fluid (CSF) alpha …
Parkinson's disease. However, genetic modifiers of cerebrospinal fluid (CSF) alpha …
Proteome Wide Association Studies of LRRK2 variants identify novel causal and druggable for Parkinson's disease
B Phillips, D Western, L Wang, J Timsina, Y Sun… - medRxiv, 2023 - medrxiv.org
Common and rare variants in the LRRK2 locus are associated with Parkinson's disease
(PD) risk, but the downstream effects of these variants on protein levels remains unknown …
(PD) risk, but the downstream effects of these variants on protein levels remains unknown …